References
Schlemmer M (2005) Desmoid tumors and deep fibromatosis. Hematol Oncol Clin North Am 19:565–571
Lefevre JH, Parc Y, Kernéis S et al (2008) Risk factors for development of desmoid tumours in familial adenomatous polyposis. Br J Surg 95:1136–1139
Fallen T, Wilson M, Morlan B, Lindor NM (2006) Desmoid tumors—a characterization of patients seen at Mayo Clinic 1976–1999. Fam Cancer 5:191–194
Soravia C, Berk T, McLeod RS et al (2000) Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 43:363–369
DeVita VT Jr, Lawrence TS, Rosenberg SA et al (2008) DeVita, Hellman, and Rosenberg’s cancer: principles and practice of oncology, 8th edn. Lippincott Williams and Wilkins, Philadelphia
Speake D, Evans DG, Lallo F et al (2007) Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg 94:1009–1013
Smith AJ, Lewis JJ, Merchant NB et al (2000) Surgical management of intra-abdominal desmoid tumors. Br J Surg 87:608–613
Bertagnolli MM, Morgan JA, Fletcher CDM et al (2008) Multimodality treatment of mesenteric desmoid tumours. Eur J Canc 44:2404–2410
Hansmann A, Adolph C, Vogel T et al (2004) High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100:612–620
Heinrich MC, McArthur GA, Demetri GD et al (2006) Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumors). J Clin Oncol 24:1195–1203
Stoeckle E, Coindre JM, Longy M et al (2009) A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. Eur J Surg Oncol 35:129–134
Lev D, Kotilingam D, Wei C et al (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 13:1785–1791
Patel SR, Benjamin RS (2006) Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol 24:11–12
Constantinidou A, Jones RL, Scurr M et al (2010) Advanced aggressive fibromatosis: effective palliation with chemotherapy. Acta Oncol. doi:10.3109/0284186X.2010.509105
de Camargo VP, Keohan ML, D’Adamo DR et al (2010) Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 116:2258–2265
Gega M, Yanagi H, Yoshikawa R et al (2006) Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 24:103–105
Wright MA, Schuler B, Szabo E, Grem JL (2003) Sustained partial response of an intra-abdominal desmoid tumor treated with gemcitabine, 5-fluorouracil and leucovorin (letters to the editor). Ann Oncol 14:659–660
Okuno SH, Edmonson JH (2003) Combination chemotherapy for desmoid tumors. Cancer 97:1134–1135
Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 23:2335–2342
Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62
Conflict of interests
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Costa, L.A., Cezana, L., Oliveira, T.B. et al. Successful treatment of an intra-abdominal desmoid tumor with irinotecan, fluorouracil, and leucovorin plus bevacizumab in a patient with familial adenomatous polyposis. Int J Colorectal Dis 27, 257–259 (2012). https://doi.org/10.1007/s00384-011-1201-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-011-1201-0